Richard Sanford Finkel MD

Child Neurology•Memphis, TN

Neuromuscular Medicine

Director, Center for Experimental Neurotherapeutics at St. Jude Children's Research Hospital

Join to View Full Profile

St. Jude Children's Research Hospital262 Danny Thomas PlaceMemphis, TN 38105

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1980 - 1983
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1978 - 1980
Washington University in St. Louis School of MedicineClass of 1978

Certifications & Licensure

FL State Medical License 2012 - 2026
IL State Medical License 2023 - 2026
KY State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
TN State Medical License 2020 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
PA State Medical License 1999 - 2014
CO State Medical License 1983 - 2001
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Join now to see all

Clinical Trials

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy Start of enrollment: 2005 Dec 01
Completed
Phase 2
A Pilot Study of Biomarkers for Spinal Muscular Atrophy Start of enrollment: 2008 Oct 01
Completed
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 Start of enrollment: 2010 May 01
Recruiting
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT Start of enrollment: 2010 Apr 01
Recruiting
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Start of enrollment: 2014 Apr 17
Completed
Phase 2
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
COMPLETED
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy Start of enrollment: 2017 Jun 06
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial.
Thomas O Crawford, Laurent Servais, Eugenio Mercuri, Heike Kölbel, Nancy Kuntz
The Lancet. Neurology. 2025-09-01
Development of the "SMA NNE," a short neonatal neurological examination for newborns with spinal muscular atrophy.
Eugenio Mercuri, Giorgia Coratti, Costanza Cutrona, Roberto De Sanctis, Giulia Stanca
European Journal of Pediatrics. 2025-08-19
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.
Craig M McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsadi, John F Brandsema
Annals of Clinical and Translational Neurology. 2025-08-19

Press Mentions

Start Spinal Muscular Atrophy Treatment at Birth?August 15th, 2025
HIV Drugs and Alzheimer's; Duchenne Drug Shows Benefit; PFAS and Cognitive ChangesMay 13th, 2025
St. Jude Neurologist Richard Finkel Named to TIME100 HealthMay 8th, 2025
Join now to see all